{"id":3588,"date":"2021-01-04T18:44:36","date_gmt":"2021-01-04T17:44:36","guid":{"rendered":"https:\/\/www.ab-science.com\/?page_id=3588"},"modified":"2021-01-04T18:49:31","modified_gmt":"2021-01-04T17:49:31","slug":"investisseurs","status":"publish","type":"page","link":"https:\/\/www.ab-science.com\/fr\/investisseurs\/","title":{"rendered":"Investisseurs"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-29f2f80199cc0a388c7d423939723cda {\n  border-radius: 12px;\n  font-size: 20px;\n  line-height: 22px;\n}\n.btn-shadow#default-btn-29f2f80199cc0a388c7d423939723cda {\n  box-shadow: 0 1px 6px rgba(0,0,0,0.12);\n  transition: box-shadow 0.2s ease-out, opacity 0.45s;\n}\n.btn-shadow#default-btn-29f2f80199cc0a388c7d423939723cda:hover {\n  box-shadow: 0 5px 11px 0 rgba(0,0,0,0.18), 0 4px 15px 0 rgba(0,0,0,0.15);\n}\n.btn-3d#default-btn-29f2f80199cc0a388c7d423939723cda {\n  box-shadow: 0px 2px 0px 0px #241128;\n}\n.btn-3d#default-btn-29f2f80199cc0a388c7d423939723cda:hover {\n  box-shadow: 0px 2px 0px 0px #241128;\n}\n.btn-flat#default-btn-29f2f80199cc0a388c7d423939723cda {\n  box-shadow: none;\n}\n.btn-flat#default-btn-29f2f80199cc0a388c7d423939723cda:hover {\n  box-shadow: none;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda > i {\n  margin-right: 8px;\n  font-size: 12px;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda:not(:hover) {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #50185f !important;\n  padding: 18px 18px 18px 18px;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda:not(:hover) * {\n  color: #ffffff;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda:hover {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #50185f !important;\n  padding: 18px 18px 18px 18px;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda:hover * {\n  color: #ffffff;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-29f2f80199cc0a388c7d423939723cda > i {\n  margin-right: 8px;\n}<\/style><div class=\"btn-align-center\"><a href=\"#\" class=\"default-btn-shortcode dt-btn fadeIn animate-element animation-builder btn-hover-off link-hover-off full-width-btn btn-flat \" id=\"default-btn-29f2f80199cc0a388c7d423939723cda\"><span>Portefeuille diversifi\u00e9 avec plusieurs programmes avanc\u00e9s<\/span><\/a><\/div>[\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1608112306766{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb]<\/p>\r\n<ul>\r\n<li>Le masitinib est en phase 2B\/3 de d\u00e9veloppement <b>dans 8 indications simultan\u00e9ment<\/b><\/li>\r\n<li><strong>Sept publications positives de phase 2B\/3,<\/strong> dans la scl\u00e9rose lat\u00e9rale amyotrophique (SLA), les formes progressives de scl\u00e9rose en plaques (SEP-PP et SEP-SP), la mastocytose syst\u00e9mique indolente (MSI), l&rsquo;asthme s\u00e9v\u00e8re non contr\u00f4l\u00e9 par les cortico\u00efdes oraux, l&rsquo;asthme s\u00e9v\u00e8re non contr\u00f4l\u00e9 par les cortico\u00efdes inhal\u00e9s, le cancer du pancr\u00e9as avec douleur et la maladie d&rsquo;Alzheimer.<\/li>\r\n<\/ul>\r\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-69d814780d9f5\" data-id=\"69d814780d9f5\" data-height=\"30\" data-height-mobile=\"15\" data-height-tab=\"30\" data-height-tab-portrait=\"30\" data-height-mobile-landscape=\"15\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\r\n<!-- \/wp:post-content -->\r\n<p><!-- wp:shortcode -->[\/vc_column_text][\/vc_column][\/vc_row][vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-591f0e591c8f8dcebbaf0727ecdfd196 {\n  border-radius: 12px;\n  font-size: 20px;\n  line-height: 22px;\n}\n.btn-shadow#default-btn-591f0e591c8f8dcebbaf0727ecdfd196 {\n  box-shadow: 0 1px 6px rgba(0,0,0,0.12);\n  transition: box-shadow 0.2s ease-out, opacity 0.45s;\n}\n.btn-shadow#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:hover {\n  box-shadow: 0 5px 11px 0 rgba(0,0,0,0.18), 0 4px 15px 0 rgba(0,0,0,0.15);\n}\n.btn-3d#default-btn-591f0e591c8f8dcebbaf0727ecdfd196 {\n  box-shadow: 0px 2px 0px 0px #0c141d;\n}\n.btn-3d#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:hover {\n  box-shadow: 0px 2px 0px 0px #0c141d;\n}\n.btn-flat#default-btn-591f0e591c8f8dcebbaf0727ecdfd196 {\n  box-shadow: none;\n}\n.btn-flat#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:hover {\n  box-shadow: none;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196 > i {\n  margin-right: 8px;\n  font-size: 12px;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:not(:hover) {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #133153 !important;\n  padding: 18px 18px 18px 18px;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:not(:hover) * {\n  color: #ffffff;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:hover {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #133153 !important;\n  padding: 18px 18px 18px 18px;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196:hover * {\n  color: #ffffff;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-591f0e591c8f8dcebbaf0727ecdfd196 > i {\n  margin-right: 8px;\n}<\/style><div class=\"btn-align-center\"><a href=\"#\" class=\"default-btn-shortcode dt-btn fadeIn animate-element animation-builder btn-hover-off link-hover-off full-width-btn btn-flat \" id=\"default-btn-591f0e591c8f8dcebbaf0727ecdfd196\"><span>Besoin m\u00e9dical non satisfait \u00e9lev\u00e9 et fort potentiel de march\u00e9<\/span><\/a><\/div>[\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1601557151324{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb]<\/p>\r\n<ul>\r\n<li>Les indications recherch\u00e9es sont toutes des besoins m\u00e9dicaux non satisfaits \u00e9lev\u00e9s<\/li>\r\n<li>Les indications recherch\u00e9es combinent \u00e0 la fois <b>des maladies<\/b> <b>potentielles<\/b> <b>\u00e0 succ\u00e8s<\/b> ou sont des <b>maladies<\/b> <b>orphelines<\/b><\/li>\r\n<\/ul>\r\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\r\n<!-- \/wp:shortcode -->\r\n<p><!-- wp:paragraph -->[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-69d814780db3e\" data-id=\"69d814780db3e\" data-height=\"30\" data-height-mobile=\"15\" data-height-tab=\"030\" data-height-tab-portrait=\"30\" data-height-mobile-landscape=\"15\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-c9b7386a0ec62507f488bd26f7ce9350 {\n  border-radius: 12px;\n  font-size: 20px;\n  line-height: 22px;\n}\n.btn-shadow#default-btn-c9b7386a0ec62507f488bd26f7ce9350 {\n  box-shadow: 0 1px 6px rgba(0,0,0,0.12);\n  transition: box-shadow 0.2s ease-out, opacity 0.45s;\n}\n.btn-shadow#default-btn-c9b7386a0ec62507f488bd26f7ce9350:hover {\n  box-shadow: 0 5px 11px 0 rgba(0,0,0,0.18), 0 4px 15px 0 rgba(0,0,0,0.15);\n}\n.btn-3d#default-btn-c9b7386a0ec62507f488bd26f7ce9350 {\n  box-shadow: 0px 2px 0px 0px #1b5369;\n}\n.btn-3d#default-btn-c9b7386a0ec62507f488bd26f7ce9350:hover {\n  box-shadow: 0px 2px 0px 0px #1b5369;\n}\n.btn-flat#default-btn-c9b7386a0ec62507f488bd26f7ce9350 {\n  box-shadow: none;\n}\n.btn-flat#default-btn-c9b7386a0ec62507f488bd26f7ce9350:hover {\n  box-shadow: none;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350 > i {\n  margin-right: 8px;\n  font-size: 12px;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350:not(:hover) {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #1482ad !important;\n  padding: 30px 18px 30px 18px;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350:not(:hover) * {\n  color: #ffffff;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350:hover {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #1482ad !important;\n  padding: 30px 18px 30px 18px;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350:hover * {\n  color: #ffffff;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-c9b7386a0ec62507f488bd26f7ce9350 > i {\n  margin-right: 8px;\n}<\/style><div class=\"btn-align-center\"><a href=\"#\" class=\"default-btn-shortcode dt-btn fadeIn animate-element animation-builder btn-hover-off link-hover-off full-width-btn btn-flat \" id=\"default-btn-c9b7386a0ec62507f488bd26f7ce9350\"><span>M\u00e9canisme unique d&rsquo;action<\/span><\/a><\/div>[\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1609764786086{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb]<\/p>\r\n<ul>\r\n<li>Le compos\u00e9 principal, le Masitinib, est un inhibiteur de la kinase ciblant s\u00e9lectivement le syst\u00e8me immunitaire via <b>les mastocytes et les macrophages\/microglies<\/b><\/li>\r\n<li>Le nouveau compos\u00e9, AB8939, est un d\u00e9stabilisateur synth\u00e9tique de microtubules de nouvelle g\u00e9n\u00e9ration capable de surmonter la r\u00e9sistance m\u00e9dicamenteuse<\/li>\r\n<\/ul>\r\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"ult-spacer spacer-69d814780dc71\" data-id=\"69d814780dc71\" data-height=\"30\" data-height-mobile=\"15\" data-height-tab=\"030\" data-height-tab-portrait=\"30\" data-height-mobile-landscape=\"15\" style=\"clear:both;display:block;\"><\/div>[\/vc_column][\/vc_row][vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-89e1c23ba3680eaaf1f0b6d41759c715 {\n  border-radius: 12px;\n  font-size: 20px;\n  line-height: 22px;\n}\n.btn-shadow#default-btn-89e1c23ba3680eaaf1f0b6d41759c715 {\n  box-shadow: 0 1px 6px rgba(0,0,0,0.12);\n  transition: box-shadow 0.2s ease-out, opacity 0.45s;\n}\n.btn-shadow#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:hover {\n  box-shadow: 0 5px 11px 0 rgba(0,0,0,0.18), 0 4px 15px 0 rgba(0,0,0,0.15);\n}\n.btn-3d#default-btn-89e1c23ba3680eaaf1f0b6d41759c715 {\n  box-shadow: 0px 2px 0px 0px #127ba1;\n}\n.btn-3d#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:hover {\n  box-shadow: 0px 2px 0px 0px #127ba1;\n}\n.btn-flat#default-btn-89e1c23ba3680eaaf1f0b6d41759c715 {\n  box-shadow: none;\n}\n.btn-flat#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:hover {\n  box-shadow: none;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715 > i {\n  margin-right: 8px;\n  font-size: 12px;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:not(:hover) {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #00b0f0 !important;\n  padding: 30px 18px 30px 18px;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:not(:hover) * {\n  color: #ffffff;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:hover {\n  border-width: 0px;\n  border-color: transparent !important;\n  color: #ffffff;\n  background: #00b0f0 !important;\n  padding: 30px 18px 30px 18px;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715:hover * {\n  color: #ffffff;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-89e1c23ba3680eaaf1f0b6d41759c715 > i {\n  margin-right: 8px;\n}<\/style><div class=\"btn-align-center\"><a href=\"#\" class=\"default-btn-shortcode dt-btn fadeIn animate-element animation-builder btn-hover-off link-hover-off hauteurmin full-width-btn btn-flat \" id=\"default-btn-89e1c23ba3680eaaf1f0b6d41759c715\"><span>Position en propri\u00e9t\u00e9 intellectuelle forte<\/span><\/a><\/div>[\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1604588501341{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb]<\/p>\r\n<ul>\r\n<li><b>Propri\u00e9t\u00e9 intellectuelle d\u00e9tenue \u00e0 100%<\/b> par AB Science<\/li>\r\n<li>Protection par brevet jusqu&rsquo;en 2037 pour la SLA et jusqu&rsquo;en 2036 dans les autres indications<\/li>\r\n<\/ul>\r\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\r\n<p><!-- \/wp:paragraph -->[\/vc_column_text][\/vc_column][\/vc_row]<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;][\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1608112306766{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb] Le masitinib est en phase 2B\/3 de d\u00e9veloppement dans 8 indications simultan\u00e9ment Sept publications positives de phase 2B\/3, dans la scl\u00e9rose lat\u00e9rale amyotrophique (SLA), les formes progressives de scl\u00e9rose en plaques (SEP-PP et SEP-SP), la mastocytose syst\u00e9mique indolente (MSI), l&rsquo;asthme s\u00e9v\u00e8re&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3588","page","type-page","status-publish","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Investisseurs &#8211; AB Science<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/investisseurs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investisseurs\" \/>\n<meta property=\"og:description\" content=\"[vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;][\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1608112306766{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb] Le masitinib est en phase 2B\/3 de d\u00e9veloppement dans 8 indications simultan\u00e9ment Sept publications positives de phase 2B\/3, dans la scl\u00e9rose lat\u00e9rale amyotrophique (SLA), les formes progressives de scl\u00e9rose en plaques (SEP-PP et SEP-SP), la mastocytose syst\u00e9mique indolente (MSI), l&rsquo;asthme s\u00e9v\u00e8re&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/investisseurs\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-04T17:49:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/\",\"name\":\"Investisseurs &#8211; AB Science\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2021-01-04T17:44:36+00:00\",\"dateModified\":\"2021-01-04T17:49:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investisseurs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Investisseurs &#8211; AB Science","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/investisseurs\/","og_locale":"fr_FR","og_type":"article","og_title":"Investisseurs","og_description":"[vc_row equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/3&Prime;][\/vc_column][vc_column width=\u00a0\u00bb2\/3&Prime;][vc_column_text css=\u00a0\u00bb.vc_custom_1608112306766{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}\u00a0\u00bb] Le masitinib est en phase 2B\/3 de d\u00e9veloppement dans 8 indications simultan\u00e9ment Sept publications positives de phase 2B\/3, dans la scl\u00e9rose lat\u00e9rale amyotrophique (SLA), les formes progressives de scl\u00e9rose en plaques (SEP-PP et SEP-SP), la mastocytose syst\u00e9mique indolente (MSI), l&rsquo;asthme s\u00e9v\u00e8re&hellip;","og_url":"https:\/\/www.ab-science.com\/fr\/investisseurs\/","og_site_name":"AB Science","article_modified_time":"2021-01-04T17:49:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/investisseurs\/","url":"https:\/\/www.ab-science.com\/fr\/investisseurs\/","name":"Investisseurs &#8211; AB Science","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2021-01-04T17:44:36+00:00","dateModified":"2021-01-04T17:49:31+00:00","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/investisseurs\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/investisseurs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/investisseurs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Investisseurs"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3588","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=3588"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3588\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=3588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}